INDIVIOR UK LIMITED v. DR. REDDY'S LABORATORIES S.A.
Before Lourie, Linn, and Dyk. Appeal from the Patent Trial and Appeal Board.
Summary: Claims of a continuation application were anticipated because they were not...more
TRAXCELL TECHNOLOGIES, LLC V. NOKIA SOLUTIONS AND NETWORKS Before Prost, O’Malley, and Stoll.
Appeal from the Eastern District of Texas.
Summary: An applicant’s arguments distinguishing prior art during patent...more
BELCHER PHARMACEUTICALS v. HOSPIRA, INC.
Before Reyna, Taranto, and Stoll. Appeal from the District of Delaware.
Summary: A patentee committed inequitable conduct by advancing an argument during patent prosecution...more
9/2/2021
/ Failure To Disclose ,
Hatch-Waxman ,
Hospira ,
Inequitable Conduct ,
Intellectual Property Protection ,
Patent Applications ,
Patent Infringement ,
Patent Litigation ,
Patent Prosecution ,
Pharmaceutical Industry ,
Pharmaceutical Patents ,
Prior Art
SYNQOR, INC. v. VICOR CORPORATION -
Before Dyk, Clevenger, and Hughes. Appeal from the Patent Trial and Appeal Board.
Summary: A finding during inter partes reexamination that two references would not be combined...more
EGENERA, INC. v. CISCO SYSTEMS, INC.
Before Prost, Stoll, and Reyna. Appeal from the United States District Court for the District of Massachusetts.
Summary: A patentee that successfully petitioned to correct a patent’s...more
9/2/2020
/ Claim Construction ,
Denial of Institution ,
Inter Partes Review (IPR) Proceeding ,
Judicial Estoppel ,
Means-Plus-Function ,
Patent Invalidity ,
Patent Litigation ,
Patent Trial and Appeal Board ,
Patents ,
Prior Art ,
Remand
B/E AEROSPACE, INC. v. C&D ZODIAC, INC.
Before Lourie, Reyna, and Hughes. Appeal from the Patent Trial and Appeal Board.
Summary: Common sense may be invoked in obviousness determination if accompanied by reasoned...more
SHOES BY FIREBUG LLC v. STRIDE RITE CHILDREN'S GROUP -
Before Lourie, Moore, and O’Malley. Appeal from the Patent Trial and Appeal Board.
Summary: In similar claims of two related patents, one preamble was limiting...more
PERSION PHARMACEUTICALS LLC v. ALVOGEN MALTA OPERATIONS LTD.
Before O’Malley, Reyna, and Chen. Appeal from the U.S. District Court for the District of Delaware.
Summary: The FDA’s acceptance of safety data for a...more
12/30/2019
/ Appeals ,
Evidence ,
FDA Approval ,
Motivation to Combine ,
Obviousness ,
Patent Infringement ,
Patent Invalidity ,
Patent Litigation ,
Patents ,
Pharmaceutical Patents ,
Prior Art ,
Reaffirmation
In the recent Two-Way Media v. Comcast decision, the Federal Circuit affirmed a district court’s holding that evidence of non-obviousness was irrelevant to patent eligibility under the Supreme Court’s two-step Alice...more